Ga. Noskin et al., ENTEROCOCCUS-FAECIUM AND ENTEROCOCCUS-FAECALIS BACTEREMIA - ACQUISITION AND OUTCOME, Clinical infectious diseases, 20(2), 1995, pp. 296-301
The incidence of enterococcal bacteremia due to Enterococcus faecium i
s increasing. To understand the clinical significance of E. faecium ba
cteremia, we compared 16 patients who were bacteremic due to E. faeciu
m to 56 patients who were bacteremic due to Enterococcus faecalis. E.
faecium bacteremia developed most frequently in severely ill patients
with fever or hypothermia accompanied by CNS, cardiovascular, and/or p
ulmonary dysfunction, while E. faecalis bacteremia occurred most often
in less seriously ill patients. Nosocomial acquisition, cancer, neutr
openia, renal insufficiency, current corticosteroid therapy, and previ
ous treatment with broad-spectrum antibiotics were significantly more
frequently associated with E. faecium bacteremia. Mortality was signif
icantly higher among patients infected with E. faecium than among thos
e infected with E. faecalis (50% vs, 11%; P = .001); this was true par
ticularly among patients with monomicrobial or nosocomial bacteremia,
those who had previously received antibiotic treatment, and those with
cancer. Death due to enterococcal bacteremia was observed only among
severely ill patients. These findings suggest that E. faecium often in
fects debilitated patients and that such infection appears to be a sig
nificant factor contributing to mortality.